ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia ; volume:39 ; number:1 ; day:11 ; month:5 ; year:2020 ; pages:1-14 ; date:12.2020
Journal of experimental & clinical cancer research ; 39, Heft 1 (11.5.2020), 1-14, 12.2020
- Creator
-
Hwang, Doh Yu
Eom, Ju-In
Jang, Ji Eun
Jeung, Hoi-Kyung
Chung, Haerim
Kim, Jin Seok
Cheong, June-Won
Min, Yoo Hong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-020-01580-4
- URN
-
urn:nbn:de:101:1-2020071701451649280378
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hwang, Doh Yu
- Eom, Ju-In
- Jang, Ji Eun
- Jeung, Hoi-Kyung
- Chung, Haerim
- Kim, Jin Seok
- Cheong, June-Won
- Min, Yoo Hong
- SpringerLink (Online service)
Other Objects (12)
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia